The controversial findings had interventional cardiologists looking for answers, with operator experience coming into focus.

Percutaneous coronary intervention (PCI) is increasingly used for revascularization of unprotected left main coronary artery disease. Whether intravascular ultrasonographic (IVUS) guidance during ...

Two trials showed novel angiography-based physiology assessments were comparable to pressure wire-based approaches for ...

Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...

Please provide your email address to receive an email when new articles are posted on . IVUS-guided PCI reduced risk for target vessel failure for patients with ACS vs. angiography-guided PCI. Lower ...

Assessing intermediate coronary lesions with an intracoronary pressure wire improves clinical outcomes in patients undergoing cardiac catheterization and percutaneous coronary intervention (PCI).

Rates of coronary angiography for patients with out-of-hospital cardiac arrest (OHCA) are similar across states with and without public reporting of PCI outcomes, according to a new study, but ...

Please provide your email address to receive an email when new articles are posted on . OCT-guided PCI conferred greater minimal stent area vs. angiography-guided PCI in the CALPISO trial. OCT-guided ...

MIAMI, FL — Use of coronary angiography and PCI after out-of-hospital cardiac arrest (OHCA) increased significantly over a 13-year period, according to new research [1]. However, "a significant ...

ATLANTA -- The use of intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in patients with acute coronary syndromes resulted in better outcomes compared with ...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were ...

ORLANDO – November 4, 2021 – The FAVOR III China trial found that lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed physiologic measurement quantitative ...